Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score

NCT07257796 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT07257796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07257796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score
Lead sponsor
Qilu Hospital of Shandong University
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2025
Completion date
December 31, 2027
Enrollment
3,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence, endoscopy, intestinal metaplasia of gastric mucosa